Dianthus Therapeutics Chief Accounting Officer Edward Carr disposes of shares for $2.01 million
Dianthus Therapeutics reported Chief Accounting Officer Edward Carr exercised stock options for 20,000 shares at USD 17.88 on Sep. 17, 2026. Carr sold 20,000 shares the same day at weighted-average prices from USD 100.43 to USD 104.39. His directly held common stock position fell to zero following the transactions. He